A Phase 1b/2 Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of TTI-101 as Monotherapy and in Combination in Participants with Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Protocol No
TVARDI-TVD-101-001H
Phase
I/II
Summary

This project is being done to evaluate the safety of TTI-101 when given either alone or
in combination treatment, and to see if it will help in the treatment of liver cancer.

Description
A Phase 1b/2 Study to Evaluate TTI-101 in Participants with HCC
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
Cancer, Pancreas/Liver, Gastrointestinal Cancers
ClinicalTrials.gov
go to website